Optimize drug development with Phesi’s Digital Patient Profile Catalogue
Regulators, payers and patient advocacy groups want program design to truly reflect patient populations. Phesi is proud to be supporting this mission with the launch of our Digital Patient Profile Catalogue which puts the patient at the heart of drug development.
Developed using Phesi’s Trial Accelerator™ platform with data from more than 60 million patients, our catalogue provides a statistical view of patient attributes such as demographics, diversity, comorbidities, concomitant medications and outcomes for key disease areas including oncology, Alzeheimer’s, Crohn’s disease and ulcerative colitis.
Our Digital Patient Profiles can help you:
Determine the right patient cohort for your study
Predict trial outcomes and improve decision making across your portfolio
Accelerate and improve trial efficiency
Satisfy regulatory requirements for patient-led development
Transition to Digital Trial Arm and Digital Twin clinical development models
